The Supreme Court agreed Friday (Jan. 10) to hear a case that could revive an Arkansas law regulating pharmacy benefit managers, a move with widespread implications for state efforts to lower drug prices through limits on PBMs’ activities and profits. The decision is a win for over 30 states and the Trump administration, as well as for community pharmacists who allege PBMs are inflating drug costs for patients. The 2015 Arkansas law required PBMs in the state to reimburse pharmacies...